StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hansa Biopharma AB (publ)
Stockholm Stock Exchange:HNSA.ST
Sector
Industries
Location
Market Cap
USD 242.64 M
Share Price
USD 2.92
Avg Daily Volume
231,100
Change (1 day)
4.13%
Change (1 year)
-25.00%
Change (YTD)
-17.59%
Hansa Biopharma AB (publ) Shareholders' Equity for the year ending December 31, 2024: USD -53.08 M
Hansa Biopharma AB (publ) Shareholders' Equity is USD -53.08 M for the year ending December 31, 2024, a 220.38% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Hansa Biopharma AB (publ) Shareholders' Equity for the year ending December 31, 2023 was USD -16.57 M, a -128.78% change year over year.
-
Hansa Biopharma AB (publ) Shareholders' Equity for the year ending December 31, 2022 was USD 57.58 M, a -30.97% change year over year.
-
Hansa Biopharma AB (publ) Shareholders' Equity for the year ending December 31, 2021 was USD 83.41 M, a -44.60% change year over year.
-
Hansa Biopharma AB (publ) Shareholders' Equity for the year ending December 31, 2020 was USD 150.55 M, a 151.40% change year over year.
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%